BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38675853)

  • 1. Development and Validation of a Genotypic Assay to Quantify CXCR4- and CCR5-Tropic Human Immunodeficiency Virus Type-1 (HIV-1) Populations and a Comparison to Trofile
    Ko D; McLaughlin S; Deng W; Mullins JI; Dragavon J; Harb S; Coombs RW; Frenkel LM
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
    Weber J; Vazquez AC; Winner D; Gibson RM; Rhea AM; Rose JD; Wylie D; Henry K; Wright A; King K; Archer J; Poveda E; Soriano V; Robertson DL; Olivo PD; Arts EJ; Quiñones-Mateu ME
    J Clin Microbiol; 2013 May; 51(5):1517-27. PubMed ID: 23486708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
    Mulinge M; Lemaire M; Servais JY; Rybicki A; Struck D; da Silva ES; Verhofstede C; Lie Y; Seguin-Devaux C; Schmit JC; Bercoff DP
    PLoS One; 2013; 8(5):e60566. PubMed ID: 23667426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.
    Sierra S; Kaiser R; Lübke N; Thielen A; Schuelter E; Heger E; Däumer M; Reuter S; Esser S; Fätkenheuer G; Pfister H; Oette M; Lengauer T
    J Vis Exp; 2011 Dec; (58):. PubMed ID: 22157596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
    Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Jensen MA; Thielen A; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    J Infect Dis; 2011 Jan; 203(2):237-45. PubMed ID: 21288824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure.
    Swenson LC; Chui CK; Brumme CJ; Chan D; Woods CK; Mo T; Dong W; Chapman D; Lewis M; Demarest JF; James I; Portsmouth S; Goodrich J; Heera J; Valdez H; Harrigan PR
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6122-30. PubMed ID: 24080655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
    Ceresola ER; Nozza S; Sampaolo M; Pignataro AR; Saita D; Ferrarese R; Ripa M; Deng W; Mullins JI; Boeri E; Tambussi G; Toniolo A; Lazzarin A; Clementi M; Canducci F
    J Antimicrob Chemother; 2015 May; 70(5):1391-5. PubMed ID: 25608585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
    Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
    J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates.
    Low AJ; Dong W; Chan D; Sing T; Swanstrom R; Jensen M; Pillai S; Good B; Harrigan PR
    AIDS; 2007 Sep; 21(14):F17-24. PubMed ID: 17721088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
    Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
    Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
    Swenson LC; Moores A; Low AJ; Thielen A; Dong W; Woods C; Jensen MA; Wynhoven B; Chan D; Glascock C; Harrigan PR
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):506-10. PubMed ID: 20512044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of eight different bioinformatics tools to predict viral tropism in different human immunodeficiency virus type 1 subtypes.
    Garrido C; Roulet V; Chueca N; Poveda E; Aguilera A; Skrabal K; Zahonero N; Carlos S; García F; Faudon JL; Soriano V; de Mendoza C
    J Clin Microbiol; 2008 Mar; 46(3):887-91. PubMed ID: 18199789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients.
    Kagan RM; Johnson EP; Siaw M; Biswas P; Chapman DS; Su Z; Platt JL; Pesano RL
    PLoS One; 2012; 7(9):e46334. PubMed ID: 23029482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.
    Archer J; Weber J; Henry K; Winner D; Gibson R; Lee L; Paxinos E; Arts EJ; Robertson DL; Mimms L; Quiñones-Mateu ME
    PLoS One; 2012; 7(11):e49602. PubMed ID: 23166726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity Trofile coreceptor tropism assay.
    Sánchez V; Masiá M; Robledano C; Padilla S; Ramos JM; Gutiérrez F
    J Clin Microbiol; 2010 Nov; 48(11):4135-9. PubMed ID: 20861336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods.
    Kalu AW; Telele NF; Aralaguppe SG; Gebre-Selassie S; Fekade D; Marrone G; Sonnerborg A
    Curr HIV Res; 2018; 16(2):113-120. PubMed ID: 29766813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.